Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 9;28(3):479–488. doi: 10.1158/1078-0432.CCR-21-2781

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©2021 The Authors; Published by the American Association for Cancer Research

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

PMC Copyright notice

Figure 2. Peripheral blood CCR4+ effector Treg fractions. The percent change from baseline (A) and actual cell count (B) determined from flow cytometric analysis of peripheral blood effector Treg populations were determined prior to administration of drug at cycle 1 day 1 (C1D1), C2D1, C3D1, and C4D1. CR, complete response; PD, progressive disease; PR, partial response; SD, stable disease. — Peripheral blood CCR4⁺ effector Treg fractions. The percent change from baseline (A) and actual cell count (B) determined from flow cytometric analysis of peripheral blood effector Treg populations were determined prior to administration of drug at cycle 1 day 1 (C1D1), C2D1, C3D1, and C4D1. CR, complete response; PD, progressive disease; PR, partial response; SD, stable disease.